Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Conivaptan for Euvolemic or Hypervolemic Hyponatremia
NCT00380575Phase 3Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Aug 2000
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of conivaptan in hyponatremia, sponsored by Cumberland Pharmaceuticals. Started Aug 2000; status: completed.
02
Drugs
conivaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT00380575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380575.